Retatrutide (GLP-3) — 10mg | Triple Receptor Research

FOR RESEARCH USE ONLY — Not for human or animal consumption.

Retatrutide is a synthetic peptide triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. MW: ~4.8 kDa. Studied in preclinical models for multi-receptor pathway research, adipogenesis studies, hepatic lipid metabolism, and energy homeostasis cell research. Currently in Phase 3 clinical investigation (Eli Lilly LY3437943).

Specifications

Quantity: 10mg lyophilized powder
Purity: ≥98% HPLC
Storage: −20°C

Note: This compound has investigational drug status. Sold strictly for in vitro laboratory research use only. Not for human or animal administration.